| [1] |
Liang J, Wang WF, Xie S, et al. Expression of β-transducin repeat-containing E3 ubiquitin protein ligase in human glioma and its correlation with prognosis[J]. Oncol Lett, 2015, 9(6): 2651-2656.
|
| [2] |
程传东，牛朝诗，杨洋. HAUSP在胶质瘤中的表达及其与肿瘤级别的相关性研究[J].中华神经外科疾病研究杂志, 2014, 13(1): 4-8.
|
| [3] |
Wang Z, Liu P, Inuzuka H, et al. Roles of F-box proteins in cancer[J]. Nat Rev Cancer, 2014, 14(4): 233-247.
|
| [4] |
Long MJ, Lin HY, Parvez S, et al. β-TrCP1 is a vacillatory regulator of wnt signaling[J]. Cell Chem Biol, 2017, 24(8): 944-957.e7.
|
| [5] |
Ougolkov A, Zhang B, Yamashita K, et al. Associations among beta-TrCP, an E3 ubiquitin ligase receptor, beta-catenin, and NF-kappaB in colorectal cancer[J]. J Natl Cancer Inst, 2004, 96(15): 1161-1170.
|
| [6] |
张伟，周林，李乃义,等,胃癌组织UHRF1表达与预后相关性分析[J].中华肿瘤防治杂志, 2015, 22(2): 109-112.
|
| [7] |
Wan M, Huang J, Jhala NC, et al. SCF(beta-TrCP1) controls smad4 protein stability in pancreatic cancer cells[J]. Am J Pathol, 2005, 166(5): 1379-1392.
|
| [8] |
Gluschnaider U, Hidas G, Cojocaru G, et al. β-TrCP inhibition reduces prostate cancer cell growth via upregulation of the aryl hydrocarbon receptor[J]. PLoS One, 2012, 5(2): e9060.
|
| [9] |
Tsai WB, Chung YM, Zou Y, et al. Inhibition of FOXO3 tumor suppressor function by betaTrCP1 through ubiquitin-mediated degradation in a tumor mouse model[J]. PLoS One, 2012, 5(7): e11171.
|
| [10] |
Xia Y, Padre RC, De Mendoza TH, et al. Phosphorylation of p53 by IkappaB kinase 2 promotes its degradation by beta-TrCP[J]. Proc Natl Acad Sci USA, 2009, 106(8): 2629-2634.
|
| [11] |
Bhattacharya S, Chakraborty D, Basu M, et al. Emerging insights into HAUSP (USP7) in physiology, cancer and other diseases[J]. Signal Transduct Target Ther, 2018, 3: 17.
|
| [12] |
Cheng C, Niu C, Yang Y, et al. Expression of HAUSP in gliomas correlates with disease progression and survival of patients[J]. Oncol Rep, 2013, 29(5): 1730-1736.
|
| [13] |
Bhattacharya S, Ghosh MK. HAUSP, a novel deubiquitinase for Rb-MDM2 the critical regulator[J]. FEBS J, 2014, 281(13): 3061-3078.
|
| [14] |
Song MS, Salmena L, Carracedo A, et al. The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network[J]. Nature, 2008, 455(7214): 813-817.
|
| [15] |
Cai JB, Shi GM, Dong ZR, et al. Ubiquitin-specific protease 7 accelerates p14(ARF) degradation by deubiquitinating thyroid hormone receptor-interacting protein 12 and promotes hepatocellular carcinoma progression[J]. Hepatology, 2015, 61(5): 1603-1614.
|
| [16] |
Wang Q, Ma S, Song N, et al. Stabilization of histone demethylase PHF8 by USP7 promotes breast carcinogenesis[J]. J Clin Invest, 2016, 126(6): 2205-2220.
|
| [17] |
Wang BC, Lin GH, Wang B, et al. UHRF1 suppression promotes cell differentiation and reduces inflammatory reaction in anaplastic thyroid cancer[J]. Oncotarget, 2016, 9(62): 31945-31957.
|
| [18] |
桂珍，严枫. UHRF1在表观遗传调控和肿瘤诊治中的研究进展[J].南京医科大学学报(自然科学版), 2016, 36(2): 129-134.
|
| [19] |
Oba-Shinjo SM, Bengtson MH, Winnischofer SM, et al. Identification of novel differentially expressed genes in human astrocytomas by cDNA representational difference analysis[J]. Brain Res Mol Brain Res, 2005, 140(1-2): 25-33.
|
| [20] |
Chen H, Ma H, Inuzuka H, et al. DNA damage regulates UHRF1 stability via the SCF(β-TrCP) E3 ligase[J]. Mol Cell Biol, 2013, 33(6): 1139-1148.
|
| [21] |
Ma HH, Chen H, Guo X, et al. M phase phosphorylation of the epigenetic regulator UHRF1 regulates its physical association with the deubiquitylase USP7 and stability[J]. Proc Natl Acad Sci USA, 2012, 109(13): 4828-4833.
|